Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04356729 |
|---|---|
| Brief Title: | A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma |
| First Submitted : | April 20, 2020 |
| First Submitted that Met QC Criteria : | April 20, 2020 |
| First Posted : | April 22, 2020 |
| Last Update Submitted that Met QC Criteria : | September 20, 2023 |
| Last Update Posted : | September 21, 2023 |